Roth MKM Reiterates Buy on Immix Biopharma, Maintains $14 Price Target
BenzingaAug 14, 2023 22:11
Immix Biopharma Analyst Ratings
BenzingaAug 14, 2023 22:10
Roth MKM Keeps Their Buy Rating on Immix Biopharma, Inc. (IMMX)
TipRanksFeb 28, 2023 21:41
Immix Biopharma Analyst Ratings
Benzinga Analyst RatingsFeb 22, 2023 21:55
Roth MKM Initiates Coverage On Immix Biopharma With Buy Rating, Announces Price Target of $14
Benzinga Real-time NewsFeb 22, 2023 21:25
No Data
No Data